NM_005142.3:c.435_437delGAA

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PM4_SupportingBP6_Very_StrongBS1BS2

The NM_005142.3(CBLIF):​c.435_437delGAA​(p.Lys145del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0021 in 1,614,012 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0022 ( 3 hom. )

Consequence

CBLIF
NM_005142.3 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: 1.39

Publications

0 publications found
Variant links:
Genes affected
CBLIF (HGNC:4268): (cobalamin binding intrinsic factor) This gene is a member of the cobalamin transport protein family. It encodes a glycoprotein secreted by parietal cells of the gastric mucosa and is required for adequate absorption of vitamin B12. Vitamin B12 is necessary for erythrocyte maturation and mutations in this gene may lead to congenital pernicious anemia. [provided by RefSeq, Jul 2008]
CBLIF Gene-Disease associations (from GenCC):
  • hereditary intrinsic factor deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_005142.3. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 11-59842516-GTTC-G is Benign according to our data. Variant chr11-59842516-GTTC-G is described in ClinVar as Likely_benign. ClinVar VariationId is 208192.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0016 (244/152346) while in subpopulation AMR AF = 0.0049 (75/15298). AF 95% confidence interval is 0.00401. There are 0 homozygotes in GnomAd4. There are 118 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CBLIFNM_005142.3 linkc.435_437delGAA p.Lys145del disruptive_inframe_deletion Exon 4 of 9 ENST00000257248.3 NP_005133.2 P27352-1
CBLIFXM_011544939.4 linkc.435_437delGAA p.Lys145del disruptive_inframe_deletion Exon 4 of 9 XP_011543241.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CBLIFENST00000257248.3 linkc.435_437delGAA p.Lys145del disruptive_inframe_deletion Exon 4 of 9 1 NM_005142.3 ENSP00000257248.2 P27352-1
CBLIFENST00000525058.5 linkn.*402_*404delGAA non_coding_transcript_exon_variant Exon 4 of 9 2 ENSP00000433196.1 E9PM21
CBLIFENST00000532070.1 linkn.925_927delGAA non_coding_transcript_exon_variant Exon 3 of 3 2
CBLIFENST00000525058.5 linkn.*402_*404delGAA 3_prime_UTR_variant Exon 4 of 9 2 ENSP00000433196.1 E9PM21

Frequencies

GnomAD3 genomes
AF:
0.00160
AC:
244
AN:
152228
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00491
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00223
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00128
AC:
321
AN:
251080
AF XY:
0.00127
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00153
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.00223
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00216
AC:
3151
AN:
1461666
Hom.:
3
AF XY:
0.00219
AC XY:
1594
AN XY:
727130
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33474
American (AMR)
AF:
0.00143
AC:
64
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39694
South Asian (SAS)
AF:
0.0000928
AC:
8
AN:
86246
European-Finnish (FIN)
AF:
0.000262
AC:
14
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5616
European-Non Finnish (NFE)
AF:
0.00265
AC:
2946
AN:
1111982
Other (OTH)
AF:
0.00179
AC:
108
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
158
315
473
630
788
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00160
AC:
244
AN:
152346
Hom.:
0
Cov.:
32
AF XY:
0.00158
AC XY:
118
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41592
American (AMR)
AF:
0.00490
AC:
75
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00223
AC:
152
AN:
68030
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000312
Hom.:
0
Bravo
AF:
0.00145
EpiCase
AF:
0.00196
EpiControl
AF:
0.00166

ClinVar

Significance: Likely benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary intrinsic factor deficiency Benign:1Other:1
-
Inserm U 954, Faculté de Médecine de Nancy
Significance:not provided
Review Status:no classification provided
Collection Method:not provided

- -

Oct 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 19, 2025
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CBLIF c.435_437delGAA (p.Lys145del) results in an in-frame deletion that is predicted to remove one amino acid from the encoded protein. The observed variant frequency is slightly higher than the estimated maximal expected allele frequency for a pathogenic variant in CBLIF causing Intrinsic Factor Deficiency phenotype (0.0011). c.435_437delGAA has been observed in individuals affected with CBLIF related disorders in heterozygous state (Chery_2013, Abdrabo_2020). These report(s) do not provide unequivocal conclusions about association of the variant with Intrinsic Factor Deficiency. One publication reports experimental evidence evaluating an impact on protein function, however, does not allow convincing conclusions about the variant effect (Chery_2013). ClinVar contains an entry for this variant (Variation ID: 208192). Based on the evidence outlined above, the variant was classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.4
Mutation Taster
=71/29
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs770530971; hg19: chr11-59609989; API